期刊文献+

经尿道等离子双极电切治疗高危良性前列腺增生200例体会 被引量:4

Clinical experiences of 200 cases of high-risk benign prostate hyperplasia treated by transurethral prostectomy with the bipolar plasmakinetic technique
暂未订购
导出
摘要 目的:探讨经尿道等离子双极电切治疗高危前列腺增生的安全有效性。方法:采用经尿道等离子双极电切治疗高危前列腺增生患者200例。术后随访1~6个月,比较术前术后的前列腺症状评分、生活质量评分、最大尿流率、残余尿量。结果:所有患者均安全耐受手术并出院,术中生命体征平稳,手术时间30~95min,切除腺体25~80g,术中平均出血约60ml,无输血患者,无电切综合征及因手术加重其他脏器并发症发生,所有患者术后排尿通畅,最大尿流率等各项指标均较术前明显好转。结论:经尿道等离子双极电切用于治疗高危前列腺增生,是一种安全、有效的微创手术方法。 Objective: To evaluate the effect and safety of transurethral prostectomy with the bipolar plasmakinetic technique (PKRP) in the treatment of high-risk benign prostate hyperplasia (BPH). Methods: 200 cases of high-risk BPH patients underwent PKRP. Patients were followed up 1 to 6 months, compared before and after operation of prostate symptom score (I-PSS), quality of life score (QOS), maximum flow rate (Qmax), residual urine volume. Results: All patients tolerated surgery safely, and discharged with stable vital signs surgery, operative time 30 to 95 min, removal of the gland 25 to 80 g, mean blood loss of about 60 ml, no blood transfusion cases, no TURP syndrome, and no increase due to surgery other organ complications, postoperative voiding in all cases, the maximum flow rate and other parameters were significantly improved preoperatively. Conclusion: PKRP is a safe and effective minimally invasive means for the treatment of high-risk BPH.
出处 《中国当代医药》 2011年第21期26-28,共3页 China Modern Medicine
关键词 高危前列腺增生 等离子 经尿道电切 高危 High-risk BPH Plasmakinetic Transurethral resection High-risk
  • 相关文献

参考文献5

  • 1吴阶平,吴阶平泌尿外科学[M].济南:山东科学技术出版社,2009:1467.
  • 2高新,周祥福.微创泌尿外科手术与图谱[M].广州:广东科技出版社,2008:154-156.
  • 3王行环,瞿利军.经尿道前列腺等离子双极汽化术和电切术[J].临床泌尿外科杂志,2006,21(7):481-483. 被引量:48
  • 4LUO HX,WANG HL.Transurethral vaporization and resection of the prostate for the treatment of high risk benign prostatic hyperplasia re- port of 21 cases[J].China Journal of Endoscopy,2001,7(3):87-88.
  • 5Dunsmu IRW D,Mc FARLA NE JP,Tan A,et al.Gyrus bipolar electrova- porization vs transurethral resection of the prostate: arandomized prospective single - blind trial with 1 y follow-up[J].Prostate Cancer Prostatic Dis,2003,6(2):182-186.

共引文献112

同被引文献24

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部